Literature DB >> 28225426

Committee Opinion No. 691: Carrier Screening for Genetic Conditions.

.   

Abstract

Carrier screening is a term used to describe genetic testing that is performed on an individual who does not have any overt phenotype for a genetic disorder but may have one variant allele within a gene(s) associated with a diagnosis. Information about carrier screening should be provided to every pregnant woman. Carrier screening and counseling ideally should be performed before pregnancy because this enables couples to learn about their reproductive risk and consider the most complete range of reproductive options. A patient may decline any or all screening. When an individual is found to be a carrier for a genetic condition, his or her relatives are at risk of carrying the same mutation. The patient should be encouraged to inform his or her relatives of the risk and the availability of carrier screening. If an individual is found to be a carrier for a specific condition, the patient's reproductive partner should be offered testing in order to receive informed genetic counseling about potential reproductive outcomes. If both partners are found to be carriers of a genetic condition, genetic counseling should be offered. What follows is a detailed discussion of some of the more common genetic conditions for which carrier screening is recommended in at least some segments of the population.

Entities:  

Mesh:

Year:  2017        PMID: 28225426     DOI: 10.1097/AOG.0000000000001952

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  48 in total

1.  1 in 38 individuals at risk of a dominant medically actionable disease.

Authors:  Lonneke Haer-Wigman; Vyne van der Schoot; Ilse Feenstra; Anneke T Vulto-van Silfhout; Christian Gilissen; Han G Brunner; Lisenka E L M Vissers; Helger G Yntema
Journal:  Eur J Hum Genet       Date:  2018-10-05       Impact factor: 4.246

2.  Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudes.

Authors:  Nigel Pereira; Michelle Wood; Emerly Luong; Allison Briggs; Michael Galloway; Rose A Maxwell; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2019-02-13       Impact factor: 3.412

3.  Expanded carrier screening in gamete donors of Venezuela.

Authors:  Maria Teresa Urbina; Isaac Benjamin; Randolfo Medina; José Jiménez; Laura Trías; Jorge Lerner
Journal:  JBRA Assist Reprod       Date:  2017-12-01

4.  OB/GYN residents' training, attitudes, and comfort level regarding genetics.

Authors:  Anastasia Kathrens-Gallardo; Lauren Propst; Edward Linn; Rachel Pothast; Catherine Wicklund; Aishwarya Arjunan
Journal:  J Assist Reprod Genet       Date:  2021-09-13       Impact factor: 3.412

5.  50 Years Ago in The Journal of Pediatrics: The Antepartum Diagnosis of Genetic Diseases.

Authors:  Bimal P Chaudhari
Journal:  J Pediatr       Date:  2018-02       Impact factor: 4.406

Review 6.  Expanded carrier screening: counseling and considerations.

Authors:  Teresa N Sparks
Journal:  Hum Genet       Date:  2019-11-02       Impact factor: 4.132

7.  Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico.

Authors:  Andrew M Zeiger; Meghan E McGarry; Angel C Y Mak; Vivian Medina; Sandra Salazar; Celeste Eng; Amy K Liu; Sam S Oh; Thomas J Nuckton; Deepti Jain; Thomas W Blackwell; Hyun Min Kang; Goncalo Abecasis; Leandra Cordero Oñate; Max A Seibold; Esteban G Burchard; Jose Rodriguez-Santana
Journal:  Pediatr Pulmonol       Date:  2019-10-30

8.  Genetic counseling prior to Assisted Reproductive Technology procedures in the era of cytogenomics.

Authors:  Roberto Coco
Journal:  JBRA Assist Reprod       Date:  2018-11-01

9.  Pregnant Women's Perspectives on Expanded Carrier Screening.

Authors:  Lauren Propst; Gwendolyn Connor; Megan Hinton; Tabitha Poorvu; Jeffrey Dungan
Journal:  J Genet Couns       Date:  2018-02-23       Impact factor: 2.537

Review 10.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.